These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12752860)

  • 1. Possible international normalized ratio elevation associated with celecoxib and warfarin in an elderly psychiatric patient.
    Stoner SC; Lea JW; Dubisar BM; Farrar C
    J Am Geriatr Soc; 2003 May; 51(5):728-9. PubMed ID: 12752860
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin and celecoxib interaction.
    Mersfelder TL; Stewart LR
    Ann Pharmacother; 2000 Mar; 34(3):325-7. PubMed ID: 10917378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential interaction between celecoxib and warfarin.
    Haase KK; Rojas-Fernandez CH; Lane L; Frank DA
    Ann Pharmacother; 2000 May; 34(5):666-7. PubMed ID: 10852097
    [No Abstract]   [Full Text] [Related]  

  • 4. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors.
    Stading JA; Skrabal MZ; Faulkner MA
    Am J Health Syst Pharm; 2001 Nov; 58(21):2076-80. PubMed ID: 11715832
    [No Abstract]   [Full Text] [Related]  

  • 5. Celecoxib-induced deep-vein thrombosis.
    Chan AL
    Ann Pharmacother; 2005 Jun; 39(6):1138. PubMed ID: 15840730
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of rofecoxib and celecoxib with warfarin.
    Schaefer MG; Plowman BK; Morreale AP; Egan M
    Am J Health Syst Pharm; 2003 Jul; 60(13):1319-23. PubMed ID: 12901032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Drug Interaction between Crizotinib and Warfarin in Non-Small-Cell Lung Cancer: A Case Report.
    Kubomura Y; Ise Y; Wako T; Katayama S; Noro R; Kubota K
    J Nippon Med Sch; 2017; 84(6):291-293. PubMed ID: 29279560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.
    Dentali F; Douketis JD; Woods K; Thabane L; Foster G; Holbrook A; Crowther M
    Ann Pharmacother; 2006; 40(7-8):1241-7. PubMed ID: 16804099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Warfarin-bosentan interaction. Risk of big INR changes].
    Holm L; Jansson A; Noher H
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2248. PubMed ID: 17822204
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication.
    Malhi H; Atac B; Daly AK; Gupta S
    Postgrad Med J; 2004 Feb; 80(940):107-9. PubMed ID: 14970301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment.
    Glasheen JJ; Fugit RV; Prochazka AV
    Pharmacotherapy; 2003 Aug; 23(8):1079-80; discussion 1080. PubMed ID: 12921255
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of prothrombin time with the use of indomethacin and warfarin.
    Chan TY
    Br J Clin Pract; 1997; 51(3):177-8. PubMed ID: 9293062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring warfarin therapy. How the INR keeps your patient safe.
    Oertel LB
    Nursing; 1999 Nov; 29(11):41-4; quiz 45. PubMed ID: 10633719
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin].
    Hosono T; Kondo A; Kambayashi Y; Homma M
    Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulants in the elderly.
    Froom P; Miron E; Barak M
    Br J Haematol; 2003 Feb; 120(3):526-8. PubMed ID: 12580973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.
    Jindal D; Tandon M; Sharma S; Pillai KK
    Eur J Clin Pharmacol; 2005 Oct; 61(9):621-5. PubMed ID: 16133549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
    Siegmund HU; Burghaus R; Kubitza D; Coboeken K
    Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
    J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.